BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2667976)

  • 21. Immuno-toxicology and -pharmacology.
    Neubert D; Neubert R; Stahlmann R; Helge H
    Braz J Med Biol Res; 1989; 22(12):1457-73. PubMed ID: 2701427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of immunotoxicity: from animal studies to human biomonitoring.
    Van Loveren H; Steerenberg PA; Vos JG
    Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the prospects for regulation in immunotoxicology?
    Hastings KL
    Toxicol Lett; 1998 Dec; 102-103():267-70. PubMed ID: 10022264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and immunotoxicology of mercury: a comparative review in fish and humans.
    Sweet LI; Zelikoff JT
    J Toxicol Environ Health B Crit Rev; 2001; 4(2):161-205. PubMed ID: 11341073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinguishing between adverse and non-adverse effects. Session summary.
    Karbe E; Williams GM; Lewis RW; Kimber I; Foster PM
    Exp Toxicol Pathol; 2002 Jul; 54(1):51-5. PubMed ID: 12180802
    [No Abstract]   [Full Text] [Related]  

  • 26. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A historical perspective of immunotoxicology.
    Luster MI
    J Immunotoxicol; 2014; 11(3):197-202. PubMed ID: 24083808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo methods in immunotoxicology.
    Krakowka S
    Toxicol Pathol; 1987; 15(3):276-80. PubMed ID: 3685788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing environmental exposure in children: immunotoxicology screening.
    Phillips TM
    J Expo Anal Environ Epidemiol; 2000; 10(6 Pt 2):769-75. PubMed ID: 11138669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparative immunotoxicity of five selected compounds following developmental or adult exposure.
    Luebke RW; Chen DH; Dietert R; Yang Y; King M; Luster MI;
    J Toxicol Environ Health B Crit Rev; 2006; 9(1):1-26. PubMed ID: 16393867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.
    Hinton DM
    Toxicol Pathol; 2000; 28(3):467-78. PubMed ID: 10862567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunopharmacology of immunotoxicology, and immunorestoration.
    Caspritz G; Hadden J
    Toxicol Pathol; 1987; 15(3):320-32. PubMed ID: 3317770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of animal studies in risk assessment for immunotoxicology.
    Luster MI; Portier C; Pait DG; Germolec DR
    Toxicology; 1994 Sep; 92(1-3):229-43. PubMed ID: 7940563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma.
    Dietert RR; Zelikoff JT
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):547-60. PubMed ID: 19085948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotoxicology: hazard identification and risk assessment.
    Thomas PT
    Nutr Rev; 1998 Jan; 56(1 Pt 2):S131-4. PubMed ID: 9481134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of brain-immune interactions in immunotoxicology.
    Fuchs BA; Sanders VM
    Crit Rev Toxicol; 1994; 24(2):151-76. PubMed ID: 8037843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental toxicology evaluations--issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies.
    Ladics GS; Chapin RE; Hastings KL; Holsapple MP; Makris SL; Sheets LP; Woolhiser MR; Burns-Naas LA
    Toxicol Sci; 2005 Nov; 88(1):24-9. PubMed ID: 16120748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing strategies in immunotoxicology.
    Pallardy M; Kerdine S; Lebrec H
    Toxicol Lett; 1998 Dec; 102-103():257-60. PubMed ID: 10022262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.